Free radical mechanisms in schizophrenia and tardive dyskinesia.
about
Experimental treatment of antipsychotic-induced movement disordersRole of melatonin in schizophreniaThe ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis.Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia.Oxidative stress in schizophrenia: an integrated approach.Divergent long-term consequences of chronic treatment with haloperidol, risperidone, and bromocriptine on traumatic brain injury-induced cognitive deficitsEmerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death.Combining the Antipsychotic Drug Haloperidol and Environmental Enrichment after Traumatic Brain Injury Is a Double-Edged Sword.Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patientsInflammation and schizophrenia: alterations in cytokine levels and perturbation in antioxidative defense systems.Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion.Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.S-adenosylmethionine-dependent protein methylation in mammalian cytosol via tyrphostin modification by catechol-O-methyltransferase.
P2860
Q26740354-7BE47570-646D-4F09-B838-2E7A82E13B0FQ26825564-87CF35CC-6FA4-4988-B222-2155B3C41E0FQ33187053-B3C1B734-2E88-4340-B3C6-1E8726719949Q33350202-AB4643E9-403E-4047-B63F-F1BA23DAFF3AQ34141234-CC74BA34-3F8A-47DE-8354-CF183B29D66BQ34494844-F53956B1-7DD9-4E99-A875-4D322878A421Q35376749-E55C296B-D7B5-4660-970D-4143A306E9D0Q38545655-F5955995-6508-4149-A554-DDAF57E6B8CAQ39552320-3220A37D-8464-46A0-B75D-B022F6951616Q39921323-21D0CE79-3290-47A0-88CE-366D590FBC1FQ41976933-4BC6729B-EAA5-436E-919A-51011253CAA0Q42285193-65F235B3-EC48-4EB4-8963-C27EACDE51A9Q42627586-C8A65BC1-091C-47E9-8FBE-F58533F5CB2EQ43541836-5C44161C-292E-4560-8A87-1E630C923AC6Q44773988-227EBEA5-07CA-4A84-A6A3-61D5483A3D08Q46411896-08CF6EE9-9B21-4BD9-B7FC-6EB82180CA98
P2860
Free radical mechanisms in schizophrenia and tardive dyskinesia.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Free radical mechanisms in schizophrenia and tardive dyskinesia.
@en
type
label
Free radical mechanisms in schizophrenia and tardive dyskinesia.
@en
prefLabel
Free radical mechanisms in schizophrenia and tardive dyskinesia.
@en
P1476
Free radical mechanisms in schizophrenia and tardive dyskinesia.
@en
P2093
P304
P356
10.1016/0149-7634(94)90001-9
P577
1994-01-01T00:00:00Z